Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 20 October 2000:
Vol. 290. no. 5491, pp. 418 - 419
DOI: 10.1126/science.290.5491.418
Prev | Table of Contents | Next

News of the Week

BIOETHICS:
Helsinki's New Clinical Rules: Fewer Placebos, More Disclosure

Martin Enserink

After 3 years of intense debate, medical researchers and ethicists have agreed on international standards that would dramatically tighten the rules for clinical research and put new limitations on the risks to which patients may be exposed. Meeting in Edinburgh, U.K., on 7 October, the general assembly of the World Medical Association voted to approve a revised version of the 1964 Declaration of Helsinki, the cornerstone of clinical research ethics, that reduces ambiguity in existing guidelines and could force changes in the design of future drug trials.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Patient Preference in Clinical Trials for Headache Medication: The Patient's View.
E Leinisch-Dahlke, E Akova-Ozturk, U Bertheau, I Isberner, S Evers, and A May (2004)
Cephalalgia 24, 347-355
   Abstract »    Full Text »    PDF »
Ethical Aspects of Placebo in Migraine Research.
M Linde, A May, V Limmroth, C Dahlof, and on behalf of the Headache Masters Programme (2003)
Cephalalgia 23, 491-495
   Abstract »    Full Text »    PDF »
The Ethics of Placebo-Controlled Trials -- A Middle Ground.
E. J. Emanuel and F. G. Miller (2001)
N. Engl. J. Med. 345, 915-919
   Full Text »    PDF »
Placebo-Controlled Trials in Type 2 Diabetes.
R. I. Misbin (2001)
Diabetes Care 24, 773-774
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)